These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 15898611

  • 41. Mesalamine and relapse prevention in Crohn's disease.
    Cottone M, Cammà C.
    Gastroenterology; 2000 Aug; 119(2):597. PubMed ID: 10960274
    [No Abstract] [Full Text] [Related]

  • 42. Fever induced by mesalazine.
    Pizarro Carbajo I, Gutiérrez Macías A, Cea Gómez M, Lombide Aguirre I.
    Gastroenterol Hepatol; 2018 Apr; 41(4):261-262. PubMed ID: 28431755
    [No Abstract] [Full Text] [Related]

  • 43. Drug-induced pericarditis mimicking Brugada syndrome.
    Hermida JS, Six I, Jarry G.
    Europace; 2007 Jan; 9(1):66-8. PubMed ID: 17224428
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr 28; 147(17):58-9. PubMed ID: 15903063
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. What's new: innovative concepts in inflammatory bowel disease.
    Sandborn WJ.
    Colorectal Dis; 2006 May 28; 8 Suppl 1():3-9. PubMed ID: 16594957
    [Abstract] [Full Text] [Related]

  • 51. Collagenous colitis in a Japanese woman: successful treatment with mesalazine.
    Suzuki K, Kawabe T, Takahashi H, Nakao S, Suzuki A, Inamori M, Iida H, Endo H, Akiyama T, Fujita K, Yoneda M, Abe Y, Kobayashi N, Kubota K, Oshiro H, Nakajima A.
    Digestion; 2008 May 28; 77(3-4):155-6. PubMed ID: 18577853
    [No Abstract] [Full Text] [Related]

  • 52. Use of mesalazine in diverticular disease.
    Di Mario F, Comparato G, Fanigliulo L, Aragona G, Cavallaro LG, Cavestro GM, Franzé A.
    J Clin Gastroenterol; 2006 Aug 28; 40 Suppl 3():S155-9. PubMed ID: 16885700
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The case against using 5-aminosalicyclates in Crohn's disease: con.
    Stange EF.
    Inflamm Bowel Dis; 2005 Jun 28; 11(6):613-5. PubMed ID: 15905711
    [No Abstract] [Full Text] [Related]

  • 55. Severe exudative ascites as an initial presentation of Crohn's disease.
    Tekin F, Vatansever S, Ozütemiz O, Musoğlu A, Ilter T.
    Turk J Gastroenterol; 2005 Sep 28; 16(3):171-3. PubMed ID: 16245232
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Debate: should mesalamine be used in Crohn's disease?: comments and conclusions.
    Kamm MA.
    Inflamm Bowel Dis; 2005 Jun 28; 11(6):616-7. PubMed ID: 15905712
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.